Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of GBP 10.60 billion. The enterprise value is 11.26 billion.

Market Cap	10.60B
Enterprise Value	11.26B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	222.85M
Shares Outstanding	n/a
Shares Change (YoY)	-4.36%
Shares Change (QoQ)	-2.73%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	220.73M

Valuation Ratios

The trailing PE ratio is 24.65 and the forward PE ratio is 15.03.

PE Ratio	24.65
Forward PE	15.03
PS Ratio	3.41
PB Ratio	2.97
P/TBV Ratio	42.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.99, with an EV/FCF ratio of 14.64.

EV / Earnings	26.18
EV / Sales	3.83
EV / EBITDA	11.99
EV / EBIT	16.27
EV / FCF	14.64

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.55.

Current Ratio	3.24
Quick Ratio	2.29
Debt / Equity	0.55
Debt / EBITDA	1.96
Debt / FCF	2.54
Interest Coverage	7.74

Financial Efficiency

Return on equity (ROE) is 11.77% and return on invested capital (ROIC) is 8.20%.

Return on Equity (ROE)	11.77%
Return on Assets (ROA)	6.92%
Return on Invested Capital (ROIC)	8.20%
Return on Capital Employed (ROCE)	12.64%
Revenue Per Employee	440,372
Profits Per Employee	60,885
Employee Count	7,063
Asset Turnover	0.47
Inventory Turnover	2.30

Taxes

In the past 12 months, Hologic has paid 96.25 million in taxes.

Income Tax	96.25M
Effective Tax Rate	18.29%

Stock Price Statistics

The stock price has decreased by -12.88% in the last 52 weeks. The beta is 0.55, so Hologic's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-12.88%
50-Day Moving Average	59.87
200-Day Moving Average	69.52
Relative Strength Index (RSI)	60.84
Average Volume (20 Days)	160

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.37

Income Statement

In the last 12 months, Hologic had revenue of GBP 3.11 billion and earned 430.03 million in profits. Earnings per share was 1.85.

Revenue	3.11B
Gross Profit	1.90B
Operating Income	737.86M
Pretax Income	526.28M
Net Income	430.03M
EBITDA	967.36M
EBIT	737.86M
Earnings Per Share (EPS)	1.85

Full Income Statement

Balance Sheet

The company has 1.26 billion in cash and 1.96 billion in debt, giving a net cash position of -699.32 million.

Cash & Cash Equivalents	1.26B
Total Debt	1.96B
Net Cash	-699.32M
Net Cash Per Share	n/a
Equity (Book Value)	3.57B
Book Value Per Share	16.01
Working Capital	1.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 874.05 million and capital expenditures -105.06 million, giving a free cash flow of 768.99 million.

Operating Cash Flow	874.05M
Capital Expenditures	-105.06M
Free Cash Flow	768.99M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.01%, with operating and profit margins of 23.72% and 13.83%.

Gross Margin	61.01%
Operating Margin	23.72%
Pretax Margin	16.92%
Profit Margin	13.83%
EBITDA Margin	31.10%
EBIT Margin	23.72%
FCF Margin	24.72%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.36%
Shareholder Yield	n/a
Earnings Yield	4.06%
FCF Yield	7.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.29 and a Piotroski F-Score of 7.

Altman Z-Score	4.29
Piotroski F-Score	7